S 2238 | CAS#64815-81-2 | chromogenic substrate

MedKoo Cat#: 461632 | Name: S 2238

Description:

WARNING: This product is for research use only, not for human or veterinary use.

S 2238 is a chromogenic substrate for thrombin that is used in amidolytic assay.

Chemical Structure

S 2238

CAS#64815-81-2

Theoretical Analysis

MedKoo Cat#: 461632

Name: S 2238

CAS#: 64815-81-2

Chemical Formula: C27H36N8O5

Exact Mass: 552.2809

Molecular Weight: 552.63

Elemental Analysis: C, 58.68; H, 6.57; N, 20.28; O, 14.48

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

64815-81-2 160192-34-7 (HCl)

Synonym

S 2238; S-2238; S2238;

IUPAC/Chemical Name

N-(N2-(D-phenylalanyl)-N2-(4-nitrophenyl)-L-arginyl)piperidine-2-carboxamide

InChi Key

NTHQWZZGIFUBPR-CTDXOEGXSA-N

InChi Code

InChI=1S/C27H36N8O5/c28-21(17-18-7-2-1-3-8-18)26(38)34(19-11-13-20(14-12-19)35(39)40)23(10-6-16-32-27(29)30)25(37)33-24(36)22-9-4-5-15-31-22/h1-3,7-8,11-14,21-23,31H,4-6,9-10,15-17,28H2,(H4,29,30,32)(H,33,36,37)/t21-,22?,23+/m1/s1

SMILES Code

N=C(N)NCCC[C@@H](C(NC(C1NCCCC1)=O)=O)N(C([C@@H](CC2=CC=CC=C2)N)=O)C3=CC=C([N+]([O-])=O)C=C3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 552.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Fukuda C, Iijima K, Nakamura K. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)]. Rinsho Byori. 1981 Feb;29(2):179-82. Japanese. PubMed PMID: 6453246. 2: Girolami A, Patrassi G, Toffanin F, Saggin L. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias. Am J Clin Pathol. 1980 Jul;74(1):83-7. PubMed PMID: 7395819. 3: van Voorthuizen H, Kluft C. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238. Thromb Haemost. 1984 Dec 29;52(3):350-3. PubMed PMID: 6531759. 4: Goodnight SH Jr, Schaeffer JL, Sheth K. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assays. Am J Clin Pathol. 1980 May;73(5):639-47. PubMed PMID: 7377131. 5: Du S, Harenberg J, Krämer S, Krämer R, Wehling M, Weiss C. Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method. Ther Drug Monit. 2015 Jun;37(3):375-80. doi: 10.1097/FTD.0000000000000157. PubMed PMID: 25525760. 6: Tsuda T, Yoshimura H, Hamasaki N. Development of a new colorimetric method for protein S activity measurement. Clin Chem Lab Med. 2004 Mar;42(3):350-2. PubMed PMID: 15080571. 7: Francischetti IM, Monteiro RQ, Guimarães JA. Identification of glycyrrhizin as a thrombin inhibitor. Biochem Biophys Res Commun. 1997 Jun 9;235(1):259-63. Erratum in: Biochem Biophys Res Commun 1997 Aug 8;237(1):203. Francischetti B [corrected to Francischetti IM]. PubMed PMID: 9196073. 8: Menaldo DL, Bernardes CP, Santos-Filho NA, Moura Lde A, Fuly AL, Arantes EC, Sampaio SV. Biochemical characterization and comparative analysis of two distinct serine proteases from Bothrops pirajai snake venom. Biochimie. 2012 Dec;94(12):2545-58. doi: 10.1016/j.biochi.2012.07.007. Epub 2012 Jul 17. PubMed PMID: 22819993. 9: Lottenberg R, Hall JA, Fenton JW 2nd, Jackson CM. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins. Thromb Res. 1982 Nov 1;28(3):313-32. PubMed PMID: 7179220. 10: Hijikata-Okunomiya A, Funahara Y, Opartkiattikul N. An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma. Thromb Res. 1991 Dec 1;64(5):559-69. PubMed PMID: 1808761. 11: Witting JI, Miller TM, Fenton JW 2nd. Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditions. Thromb Res. 1987 May 15;46(4):567-74. PubMed PMID: 3617013. 12: Dang QD, Di Cera E. A simple activity assay for thrombin and hirudin. J Protein Chem. 1994 May;13(4):367-73. PubMed PMID: 7986342. 13: Doljak B, Stegnar M, Urleb U, Kreft S, Umek A, Ciglaric M, Strukelj B, Popovic T. Screening for selective thrombin inhibitors in mushrooms. Blood Coagul Fibrinolysis. 2001 Mar;12(2):123-8. PubMed PMID: 11302474. 14: Ibbotson SH, Davies JA, Grant PJ. The influence of infusions of 1-desamino-8-D-arginine vasopressin (DDAVP) in vivo on thrombin generation in vitro. Thromb Haemost. 1992 Jul 6;68(1):37-9. PubMed PMID: 1514171. 15: Köhler M, Heiden M, Harbauer G, Miyashita C, Mörsdorf S, Braun B, Ernert P, Wenzel E, Rose S, Pindur G. Comparison of different prothrombin complex concentrates--in vitro and in vivo studies. Thromb Res. 1990 Oct 1;60(1):63-70. PubMed PMID: 2148989. 16: Leach RD, DeWind SA, Slattery CW, Herrmann EC. Choline inhibition of prothrombin activation. Thromb Res. 1991 Jun 15;62(6):635-48. PubMed PMID: 1926057. 17: Sonder SA, Fenton JW 2nd. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities. Clin Chem. 1986 Jun;32(6):934-7. PubMed PMID: 3708816. 18: Hoffmann JJ, Janssen WC. Comparison of three methods for measuring PEG-hirudin in blood. Blood Coagul Fibrinolysis. 2001 Oct;12(7):577-81. PubMed PMID: 11685047. 19: Hijikata-Okunomiya A, Sangtawesin W, Funahara Y. A simple and quantitative method for the determination of tissue factor. Southeast Asian J Trop Med Public Health. 1997;28 Suppl 3:161-3. PubMed PMID: 9640620. 20: Pochet L, Servais AC, Farcas E, Bettonville V, Bouckaert C, Fillet M. Determination of inhibitory potency of argatroban toward thrombin by electrophoretically mediated microanalysis. Talanta. 2013 Nov 15;116:719-25. doi: 10.1016/j.talanta.2013.07.030. Epub 2013 Jul 31. PubMed PMID: 24148466.